1,3-Benzodioxolylpentanamine

BDP
Clinical data
Other names	1-(3,4-Methylenedioxyphenyl)-2-aminopentane; 3,4-Methylenedioxy-α-propylphenethylamine; MDPPEA; α-Propyl-1,3-benzodioxole-5-ethanamine; α-Propyl-3,4-methylenedioxyphenethylamine; α-Pr-MDPEA; 2-Amino-1-(3,4-methylenedioxyphenyl)pentane
Identifiers
	IUPAC name 1-(1,3-benzodioxol-5-yl)pentan-2-amine;
CAS Number	220491-69;
PubChem CID	22007048;
ChemSpider	13616549;
Chemical and physical data
Formula	C12H17NO2
Molar mass	207.273 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCCC(CC1=CC2=C(C=C1)OCO2)N;
	InChI InChI=1S/C12H17NO2/c1-2-3-10(13)6-9-4-5-11-12(7-9)15-8-14-11/h4-5,7,10H,2-3,6,8,13H2,1H3; Key:BWUFCVGRQFOTOA-UHFFFAOYSA-N;

1,3-Benzodioxolylpentanamine (BDP), also known as K or as 3,4-methylenedioxy-α-propylphenethylamine (MDPPEA), is a drug of the phenethylamine and amphetamine families.^[1]^[2]^[3] It is the parent compound of 1,3-benzodioxolyl-N-methylpentanamine (MBDP; methyl-K) and 1,3-benzodioxolyl-N-ethylpentanamine (EBDP; ethyl-K), as well as of pentylone (βk-MBDP).^[1]^[2]^[3] The drug was synthesized by Alexander Shulgin and described in PiHKAL.^[1] In contrast to MBDP and EBDP however, it is not known to have ever been tried by humans.^[1]^[2] Very little is known about BDP.^[1]^[2]

References

^ ^a ^b ^c ^d ^e Shulgin AT, Shulgin A (1991). PiHKAL: A Chemical Love Story (1st ed.). Berkeley, CA: Transform Press. ISBN 9780963009609. OCLC 25627628.
^ ^a ^b ^c ^d Shulgin A, Manning T, Daley PF (2011). The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds. Vol. 1. Berkeley: Transform Press. ISBN 978-0-9630096-3-0.
^ ^a ^b Trachsel D, Lehmann D, Enzensperger C (2013). Phenethylamine: von der Struktur zur Funktion [Phenethylamines: From Structure to Function]. Nachtschatten-Science (in German). Solothurn: Nachtschatten-Verlag. p. 556. ISBN 978-3-03788-700-4. OCLC 858805226. Retrieved 29 January 2025.

This psychoactive drug-related article is a stub. You can help Wikipedia by expanding it.